Exane Derivatives’s Kodak KODK Stock Holding History

Exane Derivatives’s Portfolio KODK Stock Details KODK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14,767	Closed	-$116K	–	1066
2021 Q1	$116K	Buy	14,767 +2,979	+25%	+$27.1K	0.03%	402
2020 Q4	$96K	Buy	+11,788	New	+$98.2K	0.03%	400

Other funds holding KODK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

GLA

Great Lakes Advisors Chicago, Illinois $12.1B AUM 29.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Exane Derivatives's KODK Position: Q2 2021 in Review

Exane Derivatives sold out of Kodak (KODK) in Q2 2021, closing a stake of 14,767 shares — an estimated $116K sold.

Exane Derivatives first reported a position in KODK in Q4 2020 and held it in 2 quarters. The position peaked at $116K in Q1 2021. 123 funds tracked by Wall St. Rank hold KODK as of Q2 2021.

Exane Derivatives reported no remaining Kodak position as of Q2 2021 after selling out during the quarter.
Exane Derivatives sold 14,767 Kodak shares in Q2 2021, an estimated $116K.
Exane Derivatives first reported a position in Kodak in Q4 2020 and held it in 2 quarters.
Exane Derivatives's Kodak position peaked at $116K in Q1 2021.
123 funds tracked by Wall St. Rank held Kodak as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.